BLATT LAWRENCE

CIK 00012421102 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001242110

Recent Transactions

50 trades

Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2025-07-16+179,800→ 179,800 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2025-02-28+140,103→ 140,103 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2024-09-04+33,920→ 33,920 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2024-03-01+965,435→ 965,435 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2024-02-28+132,352→ 132,352 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2024-02-28+230,999→ 230,999 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2024-02-28+57,749→ 57,749 total
Disposition to Issuer
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2024-02-27−80,850→ 0 total
Disposition to Issuer
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2024-02-27−450,000→ 0 total
Disposition to Issuer
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2024-02-27−323,400→ 0 total
Award
Aligos Therapeutics, Inc.$ALGS
Warrants (Right to Buy)
2023-10-25$0.13/sh+305,138→ 305,138 total
Award
Aligos Therapeutics, Inc.$ALGS
Common Stock
2023-10-25$0.76/sh+610,277→ 1,847,575 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2023-09-08+150,000→ 150,000 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2023-03-15+242,500→ 242,500 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2022-07-07+161,700→ 161,700 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2022-02-04+80,850→ 80,850 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2022-02-04+323,400→ 323,400 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2020-12-01+450,000→ 450,000 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Common Stock
2020-10-20+41,016→ 41,016 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Common Stock
2020-10-20+3,394→ 17,065 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Series A Preferred Stock
2020-10-20−41,016→ 0 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Series B-2 Preferred Stock
2020-10-20−1,452→ 0 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Common Stock
2020-10-20+21,695→ 113,423 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Series B-1 Preferred Stock
2020-10-20−50,712→ 0 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Common Stock
2020-10-20+13,671→ 13,671 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Common Stock
2020-10-20+1,452→ 18,517 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Series B-1 Preferred Stock
2020-10-20−3,394→ 0 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Series B-2 Preferred Stock
2020-10-20−1,452→ 0 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Common Stock
2020-10-20+122,601→ 122,601 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Common Stock
2020-10-20+50,712→ 91,728 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Common Stock
2020-10-20+3,394→ 17,065 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Series A Preferred Stock
2020-10-20−122,601→ 0 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Series A Preferred Stock
2020-10-20−13,671→ 0 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Common Stock
2020-10-20+1,452→ 18,517 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Series A Preferred Stock
2020-10-20−13,671→ 0 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Series B-2 Preferred Stock
2020-10-20−21,695→ 0 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Series B-1 Preferred Stock
2020-10-20−3,394→ 0 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Common Stock
2020-10-20+13,671→ 13,671 total
Sale
INTERMUNE INC
Common Stock
2008-05-19$15.37/sh−18,539→ 7,083 total
Exercise/Conversion
INTERMUNE INC
Common Stock
2008-05-19$10.11/sh+18,539→ 25,622 total
Exercise/Conversion
INTERMUNE INC
Non-Qualified Stock Option (right to buy)
2008-05-19−18,539→ 0 total
Tax Payment
INTERMUNE INC
Common Stock
2008-05-16$15.48/sh−376→ 7,083 total
Sale
INTERMUNE INC
Common Stock
2008-01-02$13.26/sh−3,357→ 0 total
Sale
INTERMUNE INC
Common Stock
2006-08-14$16.47/sh−200→ 19,841 total
Sale
INTERMUNE INC
Common Stock
2006-08-14$16.44/sh−1,398→ 18,143 total
Sale
INTERMUNE INC
Common Stock
2006-08-14$16.42/sh−500→ 20,941 total
Sale
INTERMUNE INC
Common Stock
2006-08-14$16.49/sh−400→ 20,041 total
Sale
INTERMUNE INC
Common Stock
2006-08-14$16.45/sh−300→ 19,541 total
Sale
INTERMUNE INC
Common Stock
2006-08-14$16.41/sh−268→ 17,875 total
Award
INTERMUNE INC
Non-Qualified Stock Option (right to buy)
2006-06-30+22,163→ 197,737 total

Companies

Recent Filings

Address

C/O ALIGOS THERAPEUTICS, INC. 1 CORPORATE DRIVE, 2ND FLOOR

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov